XML 43 R33.htm IDEA: XBRL DOCUMENT v3.22.2
Segment Information (Tables)
6 Months Ended
Jun. 30, 2022
Segment Information  
Schedule of information about reportable segments

The following table presents information about our reportable segments for the three months ended June 30, 2022 and 2021 (in thousands):

Three months ended June 30, 

    

2022

2021

    

US

    

Ex-US

    

Total

    

US

    

Ex-US

    

Total

    

Product revenue

$

22,736

$

9,407

$

32,143

$

27,680

$

9,140

$

36,820

Operating expenses:

 

  

 

  

 

  

 

  

 

  

 

  

Cost of sales - product

 

4,461

 

3,411

 

7,872

 

5,402

 

2,892

 

8,294

Cost of sales - intangible asset amortization

 

620

 

723

 

1,343

 

620

 

723

 

1,343

Research and development

 

34,409

 

2,017

 

36,426

 

43,774

 

1,985

 

45,759

Selling, general and administrative

 

26,574

 

6,016

 

32,590

 

26,351

 

6,567

 

32,918

Acquired in-process research and development

2,204

2,204

Other operating expenses

13,293

13,293

3,884

3,884

Total expenses

 

79,357

 

 

12,167

 

 

91,524

 

 

82,235

 

 

12,167

 

 

94,402

 

Operating loss

$

(56,621)

$

(2,760)

(59,381)

$

(54,555)

$

(3,027)

(57,582)

Other income (expense):

Interest expense

(9,674)

(8,770)

Foreign currency loss

(2,489)

(206)

Other income

171

107

Other income (expense), net

(11,992)

(8,869)

Loss before income taxes

(71,373)

(66,451)

Income tax benefit

41

3

Net loss

$

(71,332)

$

(66,448)

Six months ended June 30, 

    

2022

2021

    

US

    

Ex-US

    

Total

    

US

    

Ex-US

    

Total

    

Product revenue

$

47,244

$

19,146

$

66,390

$

59,381

$

15,492

$

74,873

Operating expenses:

 

  

 

  

 

  

 

  

 

  

 

  

Cost of sales - product

 

9,295

 

6,647

 

15,942

 

11,560

 

5,002

 

16,562

Cost of sales - intangible asset amortization

 

1,241

 

1,445

 

2,686

 

1,241

 

1,445

 

2,686

Research and development

 

74,874

 

3,802

 

78,676

 

94,604

 

3,960

 

98,564

Selling, general and administrative

 

50,493

 

11,310

 

61,803

 

50,672

 

12,187

 

62,859

Acquired in-process research and development

2,204

2,204

Other operating expenses

17,023

17,023

7,591

7,591

Total expenses

 

152,926

 

 

23,204

 

 

176,130

 

 

167,872

 

 

22,594

 

 

190,466

 

Operating loss

$

(105,682)

$

(4,058)

(109,740)

$

(108,491)

$

(7,102)

(115,593)

Other income (expense):

Interest expense

(18,774)

(16,807)

Foreign currency loss

(3,468)

(752)

Other income

320

290

Other income (expense), net

(21,922)

(17,269)

Loss before income taxes

(131,662)

(132,862)

Income tax benefit

162

137

Net loss

$

(131,500)

$

(132,725)